ArticleEuropean journal of pediatrics2026
Clinical characteristics of childhood essential hypertension before, during, and after the COVID-19 pandemic: a single-center retrospective study.
Article in European journal of pediatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
To evaluate temporal differences in the clinical characteristics of children diagnosed with essential hypertension before, during, and after the COVID-19 pandemic. This retrospective single-center study included 311 children aged 6-17 years diagnosed with essential hypertension between February 2018 and April 2025. Patients were classified into pre-pandemic, pandemic, and post-pandemic groups. Clinical blood pressure measurements, 24-h ambulatory blood pressure monitoring (ABPM), body mass index (BMI), antihypertensive medication use, and cardiac and renal evaluation findings were compared between groups. The proportion of diagnosed cases was 26.7% in the pre-pandemic period, 35.0% during the pandemic, and 38.3% in the post-pandemic period. Body mass index values were significantly higher in the post-pandemic group than in the pre-pandemic group (p = 0.002). Nighttime diastolic blood pressure values on ABPM were significantly higher in the post-pandemic group (p < 0.001). Age distribution was similar across periods. The proportion of patients receiving single or multiple antihypertensive medications increased in the post-pandemic period (p = 0.041).
conclusionChildren diagnosed after the pandemic demonstrated higher BMI, increased nighttime diastolic blood pressure, and greater antihypertensive treatment use, suggesting a potentially less favorable clinical profile and the need for continued follow-up. As these findings are derived from a referral-based clinical population, they should not be interpreted as evidence of a population-level increase in childhood hypertension prevalence. WHAT IS KNOWN: • Previous studies reported increases in blood pressure and obesity in children during the COVID-19 pandemic. • Changes observed in clinical populations may reflect healthcare utilization rather than true population-level prevalence. WHAT IS NEW: • A higher proportion of diagnosed childhood hypertension cases was observed post-pandemic in a referral-based population. • Post-pandemic patients had higher BMI, higher nighttime diastolic blood pressure, and increased antihypertensive medication use.
Indexed as
Identifiers
42414737What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.